SCM
VIRX

Stonepine Capital Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Stonepine Capital Management’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-500,000
Closed -$116K – 58
2024
Q3 		$116K Buy
+500,000
New +$116K 0.07% 37